Resthetics

Resthetics is a medical device company based in Houston, Texas, with a team of 5 to 9 employees. The company focuses on developing innovative solutions within the healthcare industry. Resthetics has created a system and process for capturing waste gases, specifically fluorinated anesthetics like Isoflurane, Sevoflurane, and Desflurane, from hospital operating rooms. These captured gases are then transformed into a safe, reusable form, chemically identical to their original state. Resthetics aims to provide a cost-effective solution to the significant amount of fluorinated anesthetics released annually from U.S. hospital operating rooms, estimated at $1.5 billion. The company's technology addresses the growing demand for fluorinated anesthetics driven by factors such as an aging population, increasing life expectancy, and healthcare reforms. Resthetics positions itself as a timely solution in the market, considering the rising pharmaceutical prices and the growing concern for global warming. For further inquiries or information, interested parties are encouraged to contact Daniel Weisfeld, CEO of Resthetics, directly at 713-303-0466 or via email at [email protected].